|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online August 21, 2002 as doi:10.1096/fj.02-0313fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute of Bioengineering, Miguel Hernández University, Campus of San Juan, Alicante 03550, Spain
2Correspondence: Institute of Bioengineering, Miguel Hernández University, San Juan Campus. Carretera Alicante-Valencia Km 87. 03550, Alicante, Spain. E-mail: nadal{at}umh.es
SPECIFIC AIM
The aim of the present work was to investigate the effect of a low dose of the endocrine disruptor chemical bisphenol-A (BPA) in activating the transcription factor CREB. We demonstrate that an equal dose of BPA and 17ß-estradiol (17ß-E2) activates CREB in a calcium-dependent manner via a nonclassical membrane estrogen receptor. Since these effects are elicited at concentrations as low as 10-9 M, this observation has environmental relevance.
PRINCIPAL FINDINGS
1. Membrane depolarization increases P-CREB levels in single islet cells
In pancreatic ß cells, stimulatory concentrations of glucose and extracellular high K+ cause Ca2+ influx due to membrane depolarization and opening of voltage-dependent Ca2+ channels.
In other excitable cells, depolarization-induced Ca2+ entry couples to phosphorylation of CREB on Ser133 (P-CREB), which is the activated form of CREB.
To study CREB phosphorylation in islet cells, cells in primary culture were treated with either a stimulatory glucose concentration 8 mM glucose or 50 mM KCl for 5 min; cells were analyzed 10 min later for P-CREB by immunostaining with an antibody specific for CREB phosphorylated on Ser133. Cells were also stained with ethidium to identify the total number of nuclei.
In the absence of a stimulatory glucose concentration (3 mM), few nuclei displayed P-CREB staining (Fig. 1
). Membrane depolarization with 50 mM KCl caused a maximal increase in the percentage of nuclei with P-CREB staining (Fig. 1)
. Depolarization induced by 8 mM glucose, the physiological stimulus for ß cells, increased P-CREB labeled nuclei, which was prevented in the absence of extracellular Ca2+ (Fig. 1)
.
|
2. BPA and 17ß-E2 activate CREB in a Ca2+-dependent manner via an alternative mechanism
Bisphenol-A and 17ß-estradiol elevate [Ca2+]i at concentrations as low as 1 nM; this increase in Ca2+ is due to a depolarization-induced Ca2+ influx. Since depolarization-induced Ca2+ entry couples to phosphorylation of CREB on Ser133 (P-CREB) (Fig. 1)
, we sought to investigate whether BPA and 17ß-E2 activate CREB.
When BPA and 17ß-E2 were applied at 1 nM for 5 min, the number of nuclei labeled with the anti P-CREB antibody was increased (Fig. 2
A). Remarkably, 1 nM BPA potentiates CREB activation induced by 8 mM glucose by
35% (Fig. 2A
), a percentage similar to that induced by 1 nM BPA on [Ca2+]i elevations. CREB phosphorylation induced by 17ß-E2 and BPA was abolished in the absence of extracellular calcium, consistent with the idea that activation of calcium influx by membrane depolarization is necessary for activation of CREB (Fig. 2A
).
|
Both 17ß-estradiol- and bisphenol-A-induced activation of CREB were independent of classic ERs, since the specific ER blocker ICI 182,780 was without effect (Fig. 2B
). The membrane-impermeable molecule estradiol conjugated to peroxidase (E-HRP) mimics their effects, suggesting the involvement of a membrane receptor (Fig. 2B
).
CONCLUSIONS
Most developmental effects of estrogens are explained by their binding to an intracellular estrogen receptor protein, either ER
or ERß. Reports of environmental estrogen affecting sexual development and health of wildlife suggested that endocrine disruptors function as estrogens. BPA is not an exception, it has been demonstrated to bind to both ER
and ERß, inducing different effects of genomic nature.
However, the affinity of BPA for the classic ER is
1/2000th that of the natural estrogen 17ß-E2. This relatively low potency, seems to be a general rule for most endocrine disruptors, which have potencies from 1/50th to 1/10000th those of 17ß-E2. This has opened an ongoing debate about whether the concentration of endocrine disruptors commonly found in the environment can indeed cause health disorders.
We demonstrate here, however, that BPA and 17ß-E2 are equally potent in activating the transcription factor CREB, and they do so at concentrations as low as 10-9 M. The difference is that in the present work BPA acts via a membrane receptor rather than via a nuclear ER.
We propose that BPA and 17ß-E2 act by binding to a common receptor in the plasma membrane of pancreatic ß cells. This receptor is pharmacologically different from ER
and ERß and we have named it "nonclassical membrane estrogen receptor" (ncmER) (Fig. 3
). The binding of either BPA or 17ß-E2 produces the closing of ATP-dependent potassiumchannels in a PKG-dependent manner and subsequent potentiation of calcium signals. The increase in [Ca2+]i provokes the phosphorylation of CREB (Fig. 3)
, which should modulate the transcription of genes containing upstream cAMP/Ca2+ response elements.
|
These findings show that a low dose of bisphenol-A may alter gene expression via a new pathway that involves CREB activation after binding to a ncmER. This represents a new mechanism that should help us to understand the differences found in the estrogenicity of endocrine disruptors.
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.02-0313fje; to cite this article, use FASEB J. (August 19, 2002) 10.1096/fj.02-0313fje ![]()
This article has been cited by other articles:
![]() |
J. S. Brown Jr Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia Schizophr Bull, January 31, 2008; (2008) sbm147v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pelekanou, M. Kampa, M. Kafousi, K. Dambaki, K. Darivianaki, T. Vrekoussis, E. Sanidas, D. D. Tsiftsis, E. N. Stathopoulos, and E. Castanas Erythropoietin and Its Receptor in Breast Cancer: Correlation with Steroid Receptors and Outcome Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2016 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Eliades, V Gioni, D Kletsas, A. Athanasiou, and G Eliades Oestrogenicity of orthodontic adhesive resins Eur J Orthod, August 1, 2007; 29(4): 404 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Buterin, C. Koch, and H. Naegeli Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells Carcinogenesis, August 1, 2006; 27(8): 1567 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Ho, W.-Y. Tang, J. Belmonte de Frausto, and G. S. Prins Developmental Exposure to Estradiol and Bisphenol A Increases Susceptibility to Prostate Carcinogenesis and Epigenetically Regulates Phosphodiesterase Type 4 Variant 4 Cancer Res., June 1, 2006; 66(11): 5624 - 5632. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. V. Welshons, S. C. Nagel, and F. S. vom Saal Large Effects from Small Exposures. III. Endocrine Mechanisms Mediating Effects of Bisphenol A at Levels of Human Exposure Endocrinology, June 1, 2006; 147(6): s56 - s69. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giusi, R. M. Facciolo, M. Canonaco, E. Alleva, V. Belloni, F. Dessi'-Fulgheri, and D. Santucci The Endocrine Disruptor Atrazine Accounts for a Dimorphic Somatostatinergic Neuronal Expression Pattern in Mice Toxicol. Sci., January 1, 2006; 89(1): 257 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Facciolo, M. Madeo, R. Alo, M. Canonaco, and F. Dessi-Fulgheri Neurobiological Effects of Bisphenol A May Be Mediated by Somatostatin Subtype 3 Receptors in Some Regions of the Developing Rat Brain Toxicol. Sci., December 1, 2005; 88(2): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zsarnovszky, H. H. Le, H.-S. Wang, and S. M. Belcher Ontogeny of Rapid Estrogen-Mediated Extracellular Signal-Regulated Kinase Signaling in the Rat Cerebellar Cortex: Potent Nongenomic Agonist and Endocrine Disrupting Activity of the Xenoestrogen Bisphenol A Endocrinology, December 1, 2005; 146(12): 5388 - 5396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Contreras, C. Eckstein, C. A. Smyth, M. T. Sellers, M. Vilatoba, G. Bilbao, F. G. Rahemtulla, C. J. Young, J. A. Thompson, I. H. Chaudry, et al. Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo After Transplantation in Rats Diabetes, December 1, 2003; 52(12): 2935 - 2942. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Aldridge, J. A. Gibbons, M. M. Flaherty, M. L. Kreider, J. A. Romano, and E. D. Levin Heterogeneity of Toxicant Response: Sources of Human Variability Toxicol. Sci., November 1, 2003; 76(1): 3 - 20. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |